A new study reveals several regions of the genome where mutations increase schizophrenia risk between four- and 60-fold.
The release of neurotransmitters in the brain is impaired in people with schizophrenia who have the neurexin 1 gene mutation.
Researchers report the total amount of rare genetic mutations in a person's genome can explain why those with a disease associated mutation can have vastly different symptoms.
Researchers have found full genome sequencing by examining the entire DNA code of individuals with ASD and their families. The findings look at the wide range of genetic factors associated with ASD.
Researchers discover structural changes in two genes that increase the risk for Tourette syndrome.
